This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Angelakopoulos, H.
Right arrow Articles by Hohmann, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angelakopoulos, H.
Right arrow Articles by Hohmann, E. L.

 Previous Article  |  Next Article 

Infection and Immunity, April 2000, p. 2135-2141, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Pilot Study of phoP/phoQ-Deleted Salmonella enterica Serovar Typhimurium Expressing Helicobacter pylori Urease in Adult Volunteers

Haroula Angelakopoulos and Elizabeth L. Hohmann*

Infectious Disease Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114

Received 3 November 1999/Returned for modification 22 December 1999/Accepted 7 January 2000

Attenuated Salmonella enterica serovar Typhi has been studied as an oral vaccine vector. Despite success with attenuated S. enterica serovar Typhimurium vectors in animals, early clinical trials of S. enterica serovar Typhi expressing heterologous antigens have shown that few subjects have detectable immune responses to vectored antigens. A previous clinical study of phoP/phoQ-deleted S. enterica serovar Typhi expressing Helicobacter pylori urease from a multicopy plasmid showed that none of eight subjects had detectable immune responses to the vectored antigen. In an attempt to further define the variables important for engendering immune responses to vectored antigens in humans, six volunteers were inoculated with 5 × 107 to 8 × 107 CFU of phoP/phoQ-deleted S. enterica serovar Typhimurium expressing the same antigen. Two of the six volunteers had fever; none had diarrhea, bacteremia, or other serious side effects. The volunteers were more durably colonized than in previous studies of phoP/phoQ-deleted S. enterica serovar Typhi. Five of the six volunteers seroconverted to S. enterica serovar Typhimurium antigens and had strong evidence of anti-Salmonella mucosal immune responses by enzyme-linked immunospot studies. Three of six (three of five who seroconverted to Salmonella) had immune responses in the most sensitive assay of urease-specific immunoglobulin production by blood mononuclear cells in vitro. One of these had a fourfold or greater increase in end-point immunoglobulin titer in serum versus urease. Attenuated S. enterica serovar Typhimurium appears to be more effective than S. enterica serovar Typhi for engendering immune responses to urease. Data suggest that this may be related to a greater stability of antigen-expressing plasmid in S. enterica serovar Typhimurium and/or prolonged intestinal colonization. Specific factors unique to nontyphoidal salmonellae may also be important for stimulation of the gastrointestinal immune system.

* Corresponding author. Mailing address: Infectious Diseases Division, Gray/Jackson 504, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114. Phone: (617) 724-7532. Fax: (617) 724-3761. E-mail: ehohmann{at}partners.org.

Infection and Immunity, April 2000, p. 2135-2141, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Saxena, M., Coloe, P. J., Smooker, P. M. (2009). Influence of Promoter, Gene Copy Number, and Preexisting Immunity on Humoral and Cellular Responses to a Vectored Antigen Delivered by a Salmonella enterica Vaccine. CVI 16: 78-87 [Abstract] [Full Text]  
  • Echchannaoui, H., Bianchi, M., Baud, D., Bobst, M., Stehle, J.-C., Nardelli-Haefliger, D. (2008). Intravaginal Immunization of Mice with Recombinant Salmonella enterica Serovar Typhimurium Expressing Human Papillomavirus Type 16 Antigens as a Potential Route of Vaccination against Cervical Cancer. Infect. Immun. 76: 1940-1951 [Abstract] [Full Text]  
  • Agarwal, K., Agarwal, S. (2008). Helicobacter pylori Vaccine: From Past to Future. Mayo Clin Proc. 83: 169-175 [Abstract] [Full Text]  
  • Fraillery, D., Baud, D., Pang, S. Y.-Y., Schiller, J., Bobst, M., Zosso, N., Ponci, F., Nardelli-Haefliger, D. (2007). Salmonella enterica Serovar Typhi Ty21a Expressing Human Papillomavirus Type 16 L1 as a Potential Live Vaccine against Cervical Cancer and Typhoid Fever. CVI 14: 1285-1295 [Abstract] [Full Text]  
  • Abd El Ghany, M., Jansen, A., Clare, S., Hall, L., Pickard, D., Kingsley, R. A., Dougan, G. (2007). Candidate Live, Attenuated Salmonella enterica Serotype Typhimurium Vaccines with Reduced Fecal Shedding Are Immunogenic and Effective Oral Vaccines. Infect. Immun. 75: 1835-1842 [Abstract] [Full Text]  
  • Chen, L.-M., Briones, G., Donis, R. O., Galan, J. E. (2006). Optimization of the Delivery of Heterologous Proteins by the Salmonella enterica Serovar Typhimurium Type III Secretion System for Vaccine Development. Infect. Immun. 74: 5826-5833 [Abstract] [Full Text]  
  • Stephens, J. C., Darsley, M. J., Turner, A. K. (2006). Stabilization of a Plasmid Coding for a Heterologous Antigen in Salmonella enterica Serotype Typhi Vaccine Strain CVD908-htrA by Using Site-Specific Recombination. Infect. Immun. 74: 4383-4386 [Abstract] [Full Text]  
  • Kotton, C. N., Hohmann, E. L. (2004). Enteric Pathogens as Vaccine Vectors for Foreign Antigen Delivery. Infect. Immun. 72: 5535-5547 [Full Text]  
  • Rizos, K., Lattemann, C. T., Bumann, D., Meyer, T. F., Aebischer, T. (2003). Autodisplay: Efficacious Surface Exposure of Antigenic UreA Fragments from Helicobacter pylori in Salmonella Vaccine Strains. Infect. Immun. 71: 6320-6328 [Abstract] [Full Text]  
  • Mueller, A., O'Rourke, J., Chu, P., Kim, C. C., Sutton, P., Lee, A., Falkow, S. (2003). Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc. Natl. Acad. Sci. USA 100: 12289-12294 [Abstract] [Full Text]  
  • Qadri, F., Ryan, E. T., Faruque, A. S. G., Ahmed, F., Khan, A. I., Islam, M. M., Akramuzzaman, S. M., Sack, David. A., Calderwood, S. B. (2003). Antigen-Specific Immunoglobulin A Antibodies Secreted from Circulating B Cells Are an Effective Marker for Recent Local Immune Responses in Patients with Cholera: Comparison to Antibody-Secreting Cell Responses and Other Immunological Markers. Infect. Immun. 71: 4808-4814 [Abstract] [Full Text]  
  • Londono-Arcila, P., Freeman, D., Kleanthous, H., O'Dowd, A. M., Lewis, S., Turner, A. K., Rees, E. L., Tibbitts, T. J., Greenwood, J., Monath, T. P., Darsley, M. J. (2002). Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen. Infect. Immun. 70: 5096-5106 [Abstract] [Full Text]  
  • Hindle, Z., Chatfield, S. N., Phillimore, J., Bentley, M., Johnson, J., Cosgrove, C. A., Ghaem-Maghami, M., Sexton, A., Khan, M., Brennan, F. R., Everest, P., Wu, T., Pickard, D., Holden, D. W., Dougan, G., Griffin, G. E., House, D., Santangelo, J. D., Khan, S. A., Shea, J. E., Feldman, R. G., Lewis, D. J. M. (2002). Characterization of Salmonella enterica Derivatives Harboring Defined aroC and Salmonella Pathogenicity Island 2 Type III Secretion System (ssaV) Mutations by Immunization of Healthy Volunteers. Infect. Immun. 70: 3457-3467 [Abstract] [Full Text]  
  • Garhart, C. A., Redline, R. W., Nedrud, J. G., Czinn, S. J. (2002). Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect. Immun. 70: 3529-3538 [Abstract] [Full Text]  
  • Angelakopoulos, H., Loock, K., Sisul, D. M., Jensen, E. R., Miller, J. F., Hohmann, E. L. (2002). Safety and Shedding of an Attenuated Strain of Listeria monocytogenes with a Deletion of actA/plcB in Adult Volunteers: a Dose Escalation Study of Oral Inoculation. Infect. Immun. 70: 3592-3601 [Abstract] [Full Text]  
  • Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C., Walker, R. I. (2001). Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection. Infect. Immun. 69: 3581-3590 [Abstract] [Full Text]  
  • Aballay, A., Ausubel, F. M. (2001). Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc. Natl. Acad. Sci. USA 10.1073/pnas.041613098v1 [Abstract] [Full Text]  
  • Aballay, A., Ausubel, F. M. (2001). Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc. Natl. Acad. Sci. USA 98: 2735-2739 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»